The peer-reviewed study, entitled “US Cannabis Laws Projected To Cost Generic And Brand Pharmaceutical Firms Billions”, analyzed how publicly traded pharmaceutical firms fared after adult-use or medical marijuana laws were enacted by states. According to Ziemowit Bednarek, California Polytechnic State University’s Finance Department, together with Sarah Stith, pharmaceutical stocks were worth 1.5-2% lower in only 10 days following cannabis legalization.
Cannabis grower and edibles pioneer Maya Elisabeth makes the case that your sourdough starter is…
Berlin police are warning residents after receiving reports that suspected drug samples were being left…
Cannabis culture survived through decentralized human connection. Its future depends on whether the people building…
For years, the cannabis world has treated "the entourage effect" like settled science, a comforting…
After five years, two applications, six figures in expenses, and a maze of shifting rules,…
This article was originally published in 2023. From the hash and honey oil of the…